Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3

Molecular Immunology

Volumn 46, Issue 10, 2009, Pages 2022-2028

  Groot, Arjan J ^a   Khattabi, Mohamed El ^b   Sachs, Norman ^c   van der Groep, Petra ^a   van der Wall, Elsken ^a   van Diest, Paul J ^a   Sonnenberg, Arnoud ^c   Verrips, C Theo ^b   Vooijs, Marc ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Anti adhesive VHH; Integrin; Phage display; Surface marker; VLA 3

Indexed keywords

ANTIBODY; CELL SURFACE MARKER; CELL SURFACE PROTEIN; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; VERY LATE ACTIVATION ANTIGEN 3;

ANTIBODY SCREENING; ARTICLE; CELL ADHESION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEOMICS; REVERSE PROTEOMIC METHOD;

ADHESIVENESS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; CAMELIDS, NEW WORLD; CELL ADHESION; CELL MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPRECIPITATION; INTEGRIN ALPHA3BETA1; KERATINOCYTES; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

LAMA (MAMMAL);

EID: 67349193615     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.03.002     Document Type: Article

References (60)

1. Argraves W.S., Suzuki S., Arai H., Thompson K., Pierschbacher M.D., and Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J. Cell Biol. 105 (1987) 1183-1190
2. Cardones A.R., Murakami T., and Hwang S.T. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res. 63 (2003) 6751-6757
3. Carter W.G., Wayner E.A., Bouchard T.S., and Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J. Cell Biol. 110 (1990) 1387-1404
4. Cohen F.S., Akabas M.H., and Finkelstein A. Osmotic swelling of phospholipid vesicles causes them to fuse with a planar phospholipid bilayer membrane. Science 217 (1982) 458-460
5. Conrath K.E., Wernery U., Muyldermans S., and Nguyen V.K. Emergence and evolution of functional heavy-chain antibodies in Camelidae. Dev. Comp. Immunol. 27 (2003) 87-103
6. Cortez-Retamozo V., Lauwereys M., Hassanzadeh Gh G., Gobert M., Conrath K., Muyldermans S., De Baetselier P., and Revets H. Efficient tumor targeting by single-domain antibody fragments of camels. Int. J. Cancer 98 (2002) 456-462
7. Dang L.H., Bettegowda C., Huso D.L., Kinzler K.W., and Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 15155-15160
8. de Melker A.A., Sterk L.M., Delwel G.O., Fles D.L., Daams H., Weening J.J., and Sonnenberg A. The A and B variants of the alpha 3 integrin subunit: tissue distribution and functional characterization. Lab. Invest. 76 (1997) 547-563
9. Dekker S., Toussaint W., Panayotou G., de Wit T., Visser P., Grosveld F., and Drabek D. Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses. J. Virol. 77 (2003) 12132-12139
10. Delwel G.O., de Melker A.A., Hogervorst F., Jaspars L.H., Fles D.L., Kuikman I., Lindblom A., Paulsson M., Timpl R., and Sonnenberg A. Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol. Biol. Cell 5 (1994) 203-215
11. Desmyter A., Spinelli S., Payan F., Lauwereys M., Wyns L., Muyldermans S., and Cambillau C. Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology. J. Biol. Chem. 277 (2002) 23645-23650
12. Dolk E., van Vliet C., Perez J.M., Vriend G., Darbon H., Ferrat G., Cambillau C., Frenken L.G., and Verrips T. Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins 59 (2005) 555-564
13. Dominguez-Jimenez C., Yanez-Mo M., Carreira A., Tejedor R., Gonzalez-Amaro R., Alvarez V., and Sanchez-Madrid F. Involvement of alpha3 integrin/tetraspanin complexes in the angiogenic response induced by angiotensin II. FASEB J. 15 (2001) 1457-1459
14. Dumoulin M., Conrath K., Van Meirhaeghe A., Meersman F., Heremans K., Frenken L.G., Muyldermans S., Wyns L., and Matagne A. Single-domain antibody fragments with high conformational stability. Protein Sci. 11 (2002) 500-515
15. Dumoulin M., Last A.M., Desmyter A., Decanniere K., Canet D., Larsson G., Spencer A., Archer D.B., Sasse J., Muyldermans S., Wyns L., Redfield C., Matagne A., Robinson C.V., and Dobson C.M. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 424 (2003) 783-788
16. El Khattabi M., Adams H., Heezius E., Hermans P., Detmers F., Maassen B., van der Ley P., Tommassen J., Verrips T., and Stam J. Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications. Clin. Vaccine Immunol. 13 (2006) 1079-1086
17. Els Conrath K., Lauwereys M., Wyns L., and Muyldermans S. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276 (2001) 7346-7350
18. Forsman A., Beirnaert E., Aasa-Chapman M.M., Hoorelbeke B., Hijazi K., Koh W., Tack V., Szynol A., Kelly C., McKnight A., Verrips T., de Haard H., and Weiss R.A. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J. Virol. 82 (2008) 12069-12081
19. Frenken L.G., van der Linden R.H., Hermans P.W., Bos J.W., Ruuls R.C., de Geus B., and Verrips C.T. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J. Biotechnol. 78 (2000) 11-21
20. Fukushima Y., Ohnishi T., Arita N., Hayakawa T., and Sekiguchi K. Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int. J. Cancer 76 (1998) 63-72
21. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., and Parks W.P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51 (1973) 1417-1423
22. Goldfinger L.E., Hopkinson S.B., deHart G.W., Collawn S., Couchman J.R., and Jones J.C. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J. Cell Sci. 112 Pt 16 (1999) 2615-2629
23. Gort E.H., Groot A.J., van der Wall E., van Diest P.J., and Vooijs M.A. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr. Mol. Med. 8 (2008) 60-67
24. Gort E.H., van Haaften G., Verlaan I., Groot A.J., Plasterk R.H., Shvarts A., Suijkerbuijk K.P., van Laar T., van der Wall E., Raman V., van Diest P.J., Tijsterman M., and Vooijs M. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 27 (2008) 1501-1510
25. Groot A.J., Gort E.H., van der Wall E., van Diest P.J., and Vooijs M. Conditional inactivation of HIF-1 using intrabodies. Cell Oncol. 30 (2008) 397-409
26. Groot A.J., Mengesha A., van der Wall E., van Diest P.J., Theys J., and Vooijs M. Functional antibodies produced by oncolytic clostridia. Biochem. Biophys. Res. Commun. 364 (2007) 985-989
27. Groot A.J., Verheesen P., Westerlaken E.J., Gort E.H., van der Groep P., Bovenschen N., van der Wall E., van Diest P.J., and Shvarts A. Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha. Lab. Invest. 86 (2006) 345-356
28. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., and Hamers R. Naturally occurring antibodies devoid of light chains. Nature 363 (1993) 446-448
29. Hmila I., Abdallah R.B., Saerens D., Benlasfar Z., Conrath K., Ayeb M.E., Muyldermans S., and Bouhaouala-Zahar B. VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′. Mol. Immunol. 45 (2008) 3847-3856
30. Hofman E.G., Ruonala M.O., Bader A.N., van den Heuvel D., Voortman J., Roovers R.C., Verkleij A.J., Gerritsen H.C., and van Bergen En Henegouwen P.M. EGF induces coalescence of different lipid rafts. J. Cell Sci. 121 (2008) 2519-2528
31. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., and Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19 (1991) 4133-4137
32. Joosten V., Lokman C., Van Den Hondel C.A., and Punt P.J. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb. Cell Fact. 2 (2003) 1
33. Kawahara E., Nakada N., Hikichi T., Kobayashi J., and Nakanishi I. EGF and beta1 integrin convergently regulate migration of A431 carcinoma cell through MAP kinase activation. Exp. Cell Res. 272 (2002) 84-91
34. Kim K.K., Wei Y., Szekeres C., Kugler M.C., Wolters P.J., Hill M.L., Frank J.A., Brumwell A.N., Wheeler S.E., Kreidberg J.A., and Chapman H.A. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J. Clin. Invest. 119 (2009) 213-224
35. Lefranc M.P., Pommie C., Ruiz M., Giudicelli V., Foulquier E., Truong L., Thouvenin-Contet V., and Lefranc G. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev. Comp. Immunol. 27 (2003) 55-77
36. Margadant C., Raymond K., Kreft M., Sachs N., Janssen H., and Sonnenberg A. Integrin {alpha}3{beta}1 inhibits directional migration and wound re-epithelialization in the skin. J. Cell Sci. 122 (2009) 278-288
37. Mengesha A., Dubois L., Chiu R.K., Paesmans K., Wouters B.G., Lambin P., and Theys J. Potential and limitations of bacterial-mediated cancer therapy. Front Biosci. 12 (2007) 3880-3891
38. Morini M., Mottolese M., Ferrari N., Ghiorzo F., Buglioni S., Mortarini R., Noonan D.M., Natali P.G., and Albini A. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 87 (2000) 336-342
39. Muruganandam A., Tanha J., Narang S., and Stanimirovic D. Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J. 16 (2002) 240-242
40. Nguyen B.P., Ren X.D., Schwartz M.A., and Carter W.G. Ligation of integrin alpha 3beta 1 by laminin 5 at the wound edge activates Rho-dependent adhesion of leading keratinocytes on collagen. J. Biol. Chem. 276 (2001) 43860-43870
41. Pant N., Hultberg A., Zhao Y., Svensson L., Pan-Hammarstrom Q., Johansen K., Pouwels P.H., Ruggeri F.M., Hermans P., Frenken L., Boren T., Marcotte H., and Hammarstrom L. Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J. Infect. Dis. 194 (2006) 1580-1588
42. Perez J.M., Renisio J.G., Prompers J.J., van Platerink C.J., Cambillau C., Darbon H., and Frenken L.G. Thermal unfolding of a llama antibody fragment: a two-state reversible process. Biochemistry 40 (2001) 74-83
43. Renisio J.G., Perez J., Czisch M., Guenneugues M., Bornet O., Frenken L., Cambillau C., and Darbon H. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama. Proteins 47 (2002) 546-555
44. Roovers R.C., Laeremans T., Huang L., De Taeye S., Verkleij A.J., Revets H., de Haard H.J., and van Bergen en Henegouwen P.M. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies. Cancer Immunol. Immunother. 56 (2007) 303-317
45. Rothbauer U., Zolghadr K., Tillib S., Nowak D., Schermelleh L., Gahl A., Backmann N., Conrath K., Muyldermans S., Cardoso M.C., and Leonhardt H. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 3 (2006) 887-889
46. Saerens D., Ghassabeh G.H., and Muyldermans S. Single-domain antibodies as building blocks for novel therapeutics. Curr. Opin. Pharmacol. 8 (2008) 600-608
47. Serru V., Le Naour F., Billard M., Azorsa D.O., Lanza F., Boucheix C., and Rubinstein E. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem. J. 340 Pt 1 (1999) 103-111
48. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985) 1315-1317
49. Sonnenberg A., de Melker A.A., Martinez de Velasco A.M., Janssen H., Calafat J., and Niessen C.M. Formation of hemidesmosomes in cells of a transformed murine mammary tumor cell line and mechanisms involved in adherence of these cells to laminin and kalinin. J. Cell Sci. 106 Pt 4 (1993) 1083-1102
50. Sriramarao P., Steffner P., and Gehlsen K.R. Biochemical evidence for a homophilic interaction of the alpha 3 beta 1 integrin. J. Biol. Chem. 268 (1993) 22036-22041
51. Stijlemans B., Conrath K., Cortez-Retamozo V., Van Xong H., Wyns L., Senter P., Revets H., De Baetselier P., Muyldermans S., and Magez S. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J. Biol. Chem. 279 (2004) 1256-1261
52. Symington B.E., Takada Y., and Carter W.G. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion. J. Cell Biol. 120 (1993) 523-535
53. Takada Y., Murphy E., Pil P., Chen C., Ginsberg M.H., and Hemler M.E. Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J. Cell Biol. 115 (1991) 257-266
54. Tsuji T. Physiological and pathological roles of alpha3beta1 integrin. J. Membr. Biol. 200 (2004) 115-132
55. Tsuji T., Kawada Y., Kai-Murozono M., Komatsu S., Han S.A., Takeuchi K., Mizushima H., Miyazaki K., and Irimura T. Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). Clin. Exp. Metastasis 19 (2002) 127-134
56. van Koningsbruggen S., de Haard H., de Kievit P., Dirks R.W., van Remoortere A., Groot A.J., van Engelen B.G., den Dunnen J.T., Verrips C.T., Frants R.R., and van der Maarel S.M. Llama-derived phage display antibodies in the dissection of the human disease oculopharyngeal muscular dystrophy. J. Immunol. Methods 279 (2003) 149-161
57. Verheesen P., de Kluijver A., van Koningsbruggen S., de Brij M., de Haard H.J., van Ommen G.J., van der Maarel S.M., and Verrips C.T. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody. Hum. Mol. Genet. 15 (2006) 105-111
58. Verheesen P., Roussis A., de Haard H.J., Groot A.J., Stam J.C., den Dunnen J.T., Frants R.R., Verkleij A.J., Theo Verrips C., and van der Maarel S.M. Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochim. Biophys. Acta 1764 (2006) 1307-1319
59. Verheesen P., ten Haaft M.R., Lindner N., Verrips C.T., and de Haard J.J. Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography. Biochim. Biophys. Acta 1624 (2003) 21-28
60. Wayner E.A., Carter W.G., Piotrowicz R.S., and Kunicki T.J. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J. Cell Biol. 107 (1988) 1881-1891